跳至主要内容
临床试验/EUCTR2018-002578-37-AT
EUCTR2018-002578-37-AT进行中(未招募)1 期

The effect of antibiotic eye drops on the nasal microbiome in healthy subjects - AB Agtt Nasal Microbiome

Medical University of Vienna, Department of Clinical Pharmacology0 个研究点目标入组 80 人开始时间: 2018年7月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Men and women aged between 18 and 45 years
  • Normal ophthalmic findings
  • Tear Break Up Time >10 seconds
  • Schirmer I Test > 10mm/5min
  • Ametropia = 6 diopters
  • No use of topical eye or nasal drops in the last 3 months
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Regular use of medication, abuse of alcoholic beverages or drugs
  • Participation in a clinical trial in the 3 weeks preceding the study
  • Treatment in the previous 3 weeks with any drug (except intake of hormonal contraceptives)
  • Treatment with topical or systemic antibiotics within 8 weeks before inclusion
  • Symptoms of a clinically relevant illness in the 3 weeks before the first study day
  • History or presence of gastrointestinal, liver or kidney disease, or other conditions known to interfere with distribution, metabolism or excretion of study drugs
  • Known hypersensitivity to any of the components of the IMP under investigation or other study medication
  • Pregnant or breast-feeding women
  • Women of childbearing potential (neither menopausal, nor hysterectomized, nor sterilized) not using effective contraception (i.e. oral contraceptives, intra-uterine device, contraceptive implant or condoms)

研究者

发起方
Medical University of Vienna, Department of Clinical Pharmacology

相似试验